Will This Dementia Treatment Be a Big Hit After FDA Decision?
Prevail Therapeutics shares jumped early on Tuesday after the firm announced that the FDA has granted Orphan Drug designation for its dementia treatment.
All Work
Chris Lange
BlackBerry, Conagra, FedEx, Micron, Nike and More Earnings Coming This Week
24/7 Wall St. has put together a preview of FedEx, Nike and a few of the other most prominent earnings reports expected in the week before Christmas.
Pot Stocks on the Move After New Ontario Licensing Deal
Pot stocks were a little higher on Friday after the Ontario government announced that it will abandon the current lottery system for cannabis retail.
Are Analysts Too Optimistic on Lululemon After Earnings?
While this might be a great time for Lululemon investors to lock in their gains and take profits, analysts mostly are calling for the stock to continue its massive run.
Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug
Sarepta shares jumped on Friday after the firm announced that the FDA has approved Vyondys 53 (golodirsen) for the treatment of Duchenne muscular dystrophy (DMD) in certain patients.
Does Costco Deserve More Credit for Q1 Earnings?
Costco reported mixed fiscal first-quarter financial results after the markets closed on Thursday, and shares pulled back early Friday.
Are Oracle Earnings Enough for Investors?
Oracle released fiscal second-quarter financial results after markets closed Wednesday. The firm said that it had $0.90 in earnings per share (EPS) and $9.62 billion in revenue, compared with consensus estimates that called for…
Why Wedbush Is Cautious on Homebuilders in 2020
Wedbush has a cautious view of many homebuilders for 2020 after noting that there will be tougher comps in the second half of the year while it actually sees the near-term setup as enticing.
Why This Analyst Is Staying on the Sidelines on Cisco
Cisco has been one of the weakest components of the Dow so far in 2019, and according to one analyst this might not change anytime soon.
Will Costco Keep Up the Pace With Earnings After the Close?
Costco is set to report its fiscal first-quarter financial results after the markets close on Thursday. Analysts are looking for year-over-year growth.
Wedbush’s Top Picks After ASH Annual Meeting
The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this week in Orlando, Florida.
What to Watch When Broadcom Reports
Broadcom is scheduled to release its fiscal first-quarter financial results after the markets close on Thursday.
What to Expect When Oracle Reports After the Close
Oracle is set to report its fiscal second-quarter financial results after the markets close on Thursday. The analysts are looking for year-over-year earnings growth.
Why These Breast Cancer Study Results Look So Promising
Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the 2019 San Antonio Breast Cancer Symposium.
Are Lululemon Earnings Enough for Investors?
Lululemon released fiscal third-quarter financial results after markets closed Wednesday. The company said that it had $0.96 in earnings per share (EPS) and $916 million in revenue, compared with consensus estimates that called for…
Is This Atrial Fibrillation Drug Done For After FDA Vote?
Correvio Pharma shares were crushed after the firm announced the FDA Cardiovascular and Renal Drugs Advisory Committee decision for its New Drug Application seeking approval for Brinavess. This could result in a sale of…
What to Expect When Lululemon Reports After the Close
Lululemon is scheduled to release its fiscal third-quarter financial results after the markets close on Wednesday.
Why This Cystic Fibrosis Study Is Getting a Big Boost
Proteostasis shares jumped on Wednesday after the firm announced positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance regulator modulators, PTI-801, PTI-808 and PTI-428.
Why Wedbush Sees More Upside in Nike Ahead of Earnings
Nike has been an outstanding Dow component so far in 2019, despite its exposure to China. Even though trade talks are ongoing and nothing has been fully resolved yet, one analyst sees Nike’s outperformance…
Is Semiconductor Short Interest Signaling More Market Highs?
The November 29 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.